Cite
HARVARD Citation
Shen, L. et al. (2017). Assessment of interfering factors and clinical risk associated with discontinuation of pemetrexed maintenance therapy in advanced non-squamous non-small cell lung cancer. Lung cancer. pp. 43-50. [Online].